TERMIS EU 2027

TERMIS EU 2027 is dedicated to topics in the field of tissue engineering and regenerative medicine, including new developments and discoveries.

Key Topics

• Additive manufacturing
• 3D printing and bioprinting
• Bioadhesives
• Advanced therapy medicinal products
• Biologics and growth factors
• Biofabrication
• Biomechanics, biophysical stimuli and mechanotransduction
• Biomaterials
• Bone and bone disorders (osteoporosis etc)
• Bioreactors
• Career development
• Cancer
• Cartilage, joint and arthritic conditions
• Cardiovascular
• Ceramics
• Cell therapy
• Drug Delivery
• Composite materials
• Developmental biology
• Decellularised matrices
• Differentiation
• Diabetic healing
• Education
• Disease models
• Embryonic stem cells
• Electroactive materials
• Extracellular vesicles
• Enabling technologies
• Female leadership
• Eye
• Gene editing
• Fibre technology
• Hydrogels and injectable systems
• Gene therapy
• Imaging - in vivo
• Imaging - advanced
• In vitro microenvironments
• Immunity, immunomodulation, macrophage
• In vivo and animal models
• In silico models
• Infection
• Induced pluripotent stem cells
• Interfaces - biological
• Innovation
• Intervertebral disc, spine and their disorders
• Interfaces - engineered
• Knee
• Kidney
• Multipotent (mesenchymal) stem cells
• Microenvironment and niche engineering
• Nanomaterials (inc graphene)
• Musculoskeletal (inc ligament, tendon, muscle, etc)
• Omics, bioinformatics and systems biology
• Nervous system (brain/central/peripheral, disorders)
• Outreach
• Organ-on-a-chip, lab-on-a-chip, organoids and ex vivo models
• Polymers - natural, synthetic, responsive
• Personalised medicine
• Scaling up & Manufacturing
• Publishing
• Stem cell niche
• Skin
• Translation and commercialisation (inc. clinical trials and regulatory approval)
• Stem cells - general
• Vascular systems, vascularisation and heart
• Trauma, surgery and rehabilitation
• Wound healing
• Veterinary

Who should Attend

Attendees involved in biomaterials, tissue engineering, regenerative medicine and stem cells, including:

• Engineering managers and industry executives
• Clinicians
• Young professionals
• Engineers, researchers, and scientists
• Media representatives
• Educators and students